Pfizer Strikes Deal to Sell COVID-19 Antiviral Drug in China

Pfizer has inked a deal with a Chinese-based pharmaceutical company to sell the COVID-19 antiviral Paxlovid in the country, according to Bloomberg.

The announcement with China Meheco Group, which Bloomberg reported was made in a filing with the Shanghai stock exchange, comes as China faces a surge in coronavirus infections as it eases its “zero COVID” policy.

China in February cleared the pill for use, and the companies’ agreement is effective immediately, Bloomberg reported.

Read the source article at thehill.com